Literature DB >> 6643281

3-Amino-5-hydroxybenzoic acid in antibiotic biosynthesis. VI. Directed biosynthesis studies with ansamycin antibiotics.

A M Becker, A J Herlt, G L Hilton, J J Kibby, R W Rickards.   

Abstract

Biosynthesis of the ansamycin antibiotic actamycin (2) was markedly increased by the addition of the precursor 3-amino-5-hydroxybenzoic acid (1) to the producing Streptomyces fermentation. Similar addition of the 4-chloro, 6-chloro, N-methyl and O-methyl analogues 4, 6, 5 and 7 of the amino acid 1 reduced actamycin production and did not yield structurally modified ansamycins. These results with the analogues 4, 5 and 7 indicate that the corresponding chlorine, N-methyl and O-methyl substituents present in the nuclei of various ansamycins are introduced at biosynthetic stages beyond the level of the amino acid 1.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643281     DOI: 10.7164/antibiotics.36.1323

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

1.  Genetic localization and molecular characterization of two key genes (mitAB) required for biosynthesis of the antitumor antibiotic mitomycin C.

Authors:  Y Mao; M Varoglu; D H Sherman
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

2.  Identification of AHBA biosynthetic genes related to geldanamycin biosynthesis in Streptomyces hygroscopicus 17997.

Authors:  Weiqing He; Linzhuan Wu; Qunjie Gao; Yu Du; Yiguang Wang
Journal:  Curr Microbiol       Date:  2006-02-18       Impact factor: 2.188

3.  Streptomyces autolyticus JX-47 large-insert bacterial artificial chromosome library construction and identification of clones covering geldanamycin biosynthesis gene cluster.

Authors:  Shikun Dai; Yongchang Ouyang; Guanghua Wang; Xiang Li
Journal:  Curr Microbiol       Date:  2011-05-05       Impact factor: 2.188

4.  Engineered biosynthesis of an ansamycin polyketide precursor in Escherichia coli.

Authors:  Kenji Watanabe; Mathew A Rude; Christopher T Walsh; Chaitan Khosla
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-29       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.